Literature DB >> 4012337

Treatment of leukemia with low-dose ara-C: a study of 160 cases.

L Degos, S Castaigne, H Tilly, F Sigaux, M T Daniel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4012337

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  6 in total

Review 1.  The toxicity of cytarabine.

Authors:  J Stentoft
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

2.  Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report.

Authors:  D Brenez; J Devriendt; C Lenclud; J Schmerber
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 3.  Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.

Authors:  V Heinemann; U Jehn
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

4.  In vitro exposure of leukemic cells to low concentration Arabinosyl Cytosine: no evidence of differentiation inducing activity.

Authors:  M R Motta; M Baccarani; S Rizzi; R Fanin; G Fasola; C Poluzzi; S Tura
Journal:  Blut       Date:  1987-05

5.  Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly? A report on 77 cases.

Authors:  L Detourmignies; E Wattel; J L Laï; F Bauters; P Fenaux
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

6.  Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience.

Authors:  Maël Heiblig; Mohamed Elhamri; Isabelle Tigaud; Adriana Plesa; Fiorenza Barraco; Hélène Labussière; Sophie Ducastelle; Mauricette Michallet; Franck Nicolini; Claudiu Plesa; Eric Wattel; Gilles Salles; Xavier Thomas
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-01-01       Impact factor: 2.576
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.